GRI Bio Inc (GRI) Cotización

GRI............................https://stockcharts.com/h-sc/ui?s=GRI&p=W&b=5&g=0&id=p86431144783

GRI.......................https://stockcharts.com/h-sc/ui?s=GRI&p=W&b=5&g=0&id=p86431144783

Potential here?

lol you work?

Don't need your smart ass answers. I asked a question just answer it. Maybe I was too damn busy I needed to go To work

Maybe do a tad research on the stock before posting, it's obvious 

Why the big drop this morning? 

 the Company issued new unregistered Series D-1 warrants to purchase up to an aggregate of 762,236 shares of the Company’s common stock and new unregistered Series D-2 warrants to purchase up to an aggregate of 762,236 shares of the Company’s common stock. The new Series D-1 and D-2 warrants are immediately exercisable at an exercise price of $1.00 per share. The Series D-1 warrants will have a term of five years from the issuance date and the Series D-2 warrants will have a term of eighteen months from the issuance date

Warrants at $1 ... Marc Hertz, PhD, Chief Executive Officer of GRI Bio, commented, “The proceeds from the financings we have completed since the start of this year have greatly strengthened our balance sheet and are estimated to have provided the necessary funding to advance the development of our lead program into the middle of the first quarter of 2025. With these proceeds in hand and the continued progress toward interim and topline data for our lead program, expected in the coming quarters, we believe we are well positioned to realize the full potential of GRI-0621 to provide significant benefit to IPF patients.”

GRI.................................https://stockcharts.com/h-sc/ui?s=GRI&p=W&b=5&g=0&id=p86431144783

It's just his opinion

And what is that? Why not share? 

Obviously yes

Well do you know something? 

Funny reading all these posts nobody knows shit

Keeps going down, what do you think the bottom is going to be? 

I agree, the Nov. Earnings will be on the radar.

Anyone seeing this chart? Looks like it's going to rip to me. Just needs to hold .96/.97 right? 

I agree hold onto your shares, we still have a nice road coming ahead.

StockTwits bears are attacking it hard to load up. 

Using a prior offering agreement in February to scare people. 

The original agreement was for HC to purchase warrrants at 14.3 a share. However, you need to account for the reverse split of 13-1 in July (or June?). The warrants then became exercisable at $1.

New float will be 3.69m 
Adding $800k cash to balance sheets. 

Over reaction and still undervalued. 
Waiting for the chart pumpers to come in this afternoon to run it up. 

Just my 2 cents.

Crap. WTF

Here

Yikes

Me ZZZZZZzzzzz missed some money for sleeping in....damn it.

I see. All down..down...down...except, chart aside...they have a promising arthritis drug and a Japanese patent rights. These types of things can't be viewed on a chart. Notice pharmacy stocks at the .50 range going straight up? DRUG was .90 when I found it. GRI was .60 when I found it. Institutional intrest...or deep pockets, but serious interest 🤔

News after hour Could be something for tomorrow pre market,
GRI Bio Announces Exercise of Warrants
October 21 2024 - 5:35PM
🤔

What’s thoughts on AH activity?

Chomp chomp chomp

Again.

Halted

GRI...................................https://stockcharts.com/h-sc/ui?s=GRI&p=W&b=5&g=0&id=p86431144783

Assuming Going past $2 one more round for some quick gains for latecomers

Cashed out on SYTA also your not too late for AMC it’s ready for 100% pump likely but no guarantees

Small 6am cst sell off from those that slept in. Headed north! Extremely undervalued market cap.

GM NICE EARLY ALERTS

.87 + 50%

https://x.com/SuperDuperInvst/status/1848142206382575707

$2 + 240%

GRI 1.62 + 180% flipping out now gains secured

GRI up 150% now

GRI 1.44 + 150%

$1.13 + 96%

.87 + 50%

Top 10 watchers on StockTwits now.

Additional data added here…

$GRI is very transparent on their goal here. Just read between the lines, Pharma partner or Buyout incoming!

✅Company stated earlier this year that it will have a partner or implied buyout when positive Phase2 verified proof of concept.

b2idigital.com/gri-bio

✅ News last week stating positive phase 2 data has been demonstrated, study on going.

gribio.com/gri-bio-presen…

✅ Phase 2 expected to be done this year (2024).

clinicaltrials.gov/study/NCT06331…

✅ 10-Q 8/14/24, Page 9, “Based on the Company’s current operating plan, the Company believes that its existing cash and cash equivalents will be sufficient to fund its operating expenses and capital expenditure requirements into the first quarter of 2025.”

s3.amazonaws.com/sec.irpass.cc/…

✅Nasdaq compliance due by March 2025.

✅Executives have a track record of building pharma drugs/companies and selling them off. Their profiles discuss deal markers, IP protection, acquisition/mergers.

✅2.93m shares OS

✅ GRI Bio’s key executives own the following amounts of shares:

Walter Marc Hertz, CEO, holds approximately 385,510 shares.

Albert Agro, Chief Medical Officer, owns around 172,189 shares.

Vipin Chaturvedi, Chief Scientific Officer, also owns 172,189 shares.

Leanne Kelly, Chief Financial Officer, holds 83,333 shares.

Grok has this info for insiders

Based on the latest available data up to October 19, 2024, GRI Bio, Inc. (GRI) is largely owned by insiders,

- **Joseph E. Payne** owns **29.42%** of the company, making him the largest individual shareholder with 861,250 shares.
- **Arcturus Therapeutics Holdings Inc** holds **28.82%**.
- **Walter Marc Hertz** has **13.17%**.
- **Ofir Levi** owns **6.72%**.
- **Albert Agro** and **Vipin Chaturvedi** each own **5.88%**.
- **Richard Ammer** and **Pharma Gmbh Salmon** each hold **1.61%**.

Things to note that I posted on X and ST.

✅Company stated earlier this year that it will have a partner or implied buyout when positive Phase2 verified proof of concept.

✅ News last week stating positive phase 2 data has been demonstrated, study on going.

https://gribio.com/gri-bio-presents-positive-preclinical-data-demonstrating-gri-0621s-ability-to-inhibit-invariant-natural-killer-t-inkt-cell-activity-and-reduce-important-inflammatory-and-fibrotic-drivers-in-idiopa/

✅ Phase 2 expected to be done this year (2024).

https://clinicaltrials.gov/study/NCT06331624?spons=GRI%20Bio%20Operations,%20Inc.&rank=1

✅ 10-Q 8/14/24, Page 9, “Based on the Company’s current operating plan, the Company believes that its existing cash and cash equivalents will be sufficient to fund its operating expenses and capital expenditure requirements into the first quarter of 2025.”

https://s3.amazonaws.com/sec.irpass.cc/2647/0001824293-24-000105.htm



✅Nasdaq compliance due by March 2025.

$GRI

$PLRX appears to be working on the same IPF treatment as GRI. Both in phase2a. GRI is much further along and will be done this year yet. However, PLRX has a market cap of over $900m and 60m shares!

Both basically have this treatment as their only drug in the pipeline.

If you remove $500m in plrx “assets” from market cap, GRI should be at $400m mc.


$400m mc / 2.93m shares = $136/share!

Yea, this is nuts. Lol
Out of all the runners the last few weeks, this one has to be tightest if true. That’s less than 205k shares

Maybe it will pull a DRUG move

Is there really only 2.93m shares and just over 93% is held by insiders?

How is this not going to rip to $5-20?

Big times ahead

In GRI. Looks like big bounce coming